Application of beta-ketoacyl-ACP synthase III in bacillus in promoting secretion efficiency of bacillus metabolite
By integrating the fabHB gene into Bacillus licheniformis and replacing the promoter, the limitations of Bacillus licheniformis in the efficient expression and secretion of polyγ-glutamate, nattokinase and alkaline protease were overcome, enabling the efficient synthesis and industrial production of these metabolites.
Patent Information
- Application Number
- CN202411298270.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-09-18
AI Technical Summary
Bacillus licheniformis has limitations in efficiently expressing and secreting metabolites such as poly-γ-glutamate, nattokinase, and alkaline protease, resulting in high production costs, low enzyme expression levels, and poor thermal stability, which limits its industrial application.
By integrating and overexpressing the fabHB gene (encoding β-ketoacyl-ACP synthase III) into Bacillus licheniformis, replacing the sigE gene and using different promoters (such as P43, PykzA, and PnadE), the efficient secretion and expression of metabolites can be promoted.
It significantly improved the secretion efficiency and expression level of Bacillus licheniformis metabolites, promoting the efficient synthesis and industrial production of polyγ-glutamic acid, nattokinase, and alkaline protease.
Smart Images

Figure BDA0005046784450000051 
Figure BDA0005046784450000061 
Figure BDA0005046784450000081
Abstract
Description
Technical Field
[0001] The invention belongs to the field of microorganisms, and specifically relates to the application of beta-ketoacyl-ACP synthase III in Bacillus in promoting the secretion efficiency of Bacillus metabolites. Background Art
[0002] Bacillus licheniformis has important biological applications in the food industry and pharmaceutical industry due to its strong protein expression and secretion capabilities, unique genetic background and safety characteristics. It can not only be used as an industrial strain with excellent performance to produce exogenous proteins or enzyme preparations, but also as an industrial production strain to ferment and produce high value-added chemicals such as poly-γ-glutamic acid, antibiotics, nucleotides and condiments. However, the efficient expression system of Bacillus licheniformis still limits the expression of many proteins and is currently limited to the production of a small amount of industrial enzymes.
[0003] Poly-γ-glutamic acid (γ-PGA) is a multifunctional biopolymer polymerized by D-glutamic acid and (or) L-glutamic acid monomers through γ-amide bonds. It has been used in agriculture, cosmetics, food, water treatment and medicine. As the main hydrolase in industry, alkaline protease AprE has the excellent characteristics of high catalytic activity and water solubility, and is used in detergents, leather processing and even environmental governance. As an alkaline serine protease, nattokinase AprN can dissolve blood clots through various mechanisms in vivo to prevent or treat cardiovascular diseases. It has been developed as a new thrombolytic drug. Problems such as high production cost, low enzyme expression level and poor thermal stability limit its industrial production. Therefore, further promoting the industrialization process of poly-γ-glutamic acid and realizing the efficient secretion of alkaline protease and nattokinase in Bacillus licheniformis are of great significance for its industrial production, and obtaining excellent microbial chassis cells is the basis of economic benefits.
[0004] In Bacillus, the gene fabHB encodes β-ketoacyl-ACP synthase III, and the effect of enhanced expression of fabHB on the synthesis of target products has not been reported. The present invention promotes the secretion efficiency of multiple metabolites of Bacillus licheniformis by integrating the overexpressed gene fabHB, providing effective guidance for Bacillus licheniformis as a chassis cell to increase the production of metabolites. Summary of the invention
[0005] In view of the above problems, the purpose of the present invention is to provide the use of β-ketoacyl-ACP synthase III in Bacillus in promoting the secretion efficiency of Bacillus metabolites.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] The invention discloses an application of β-ketoacyl-ACP synthase III in Bacillus to promoting the secretion efficiency of Bacillus metabolites. The β-ketoacyl-ACP synthase III is shown in SEQ ID NO.2.
[0008] In the above application, preferably, the Bacillus is Bacillus licheniformis.
[0009] In the above application, preferably, the coding gene of β-ketoacyl-ACP synthase III is shown as SEQ ID NO.1.
[0010] In the above application, preferably, the Bacillus is Bacillus licheniformis WX-02.
[0011] The above-mentioned application, preferably, comprises the following steps: replacing the sigE gene in Bacillus licheniformis WX-02 with the gene encoding β-ketoacyl-ACP synthase III in Bacillus.
[0012] In the above application, preferably, the Bacillus metabolite is γ-PGA, a metabolite of Bacillus licheniformis.
[0013] The protection scope of the present invention also includes: the use of β-ketoacyl-ACP synthase III in Bacillus in promoting the expression of foreign proteins in Bacillus licheniformis.
[0014] In the above application, preferably, the exogenous protein is nattokinase or alkaline protease.
[0015] The above-mentioned application, preferably, when the exogenous protein is nattokinase, its application process includes replacing the sigE gene in Bacillus licheniformis WX-02 with the coding gene of β-ketoacyl-ACP synthase III in Bacillus, and the promoter of the coding gene of β-ketoacyl-ACP synthase III is PnadE promoter; when the exogenous protein is alkaline protease, its application process includes replacing the sigE gene in Bacillus licheniformis WX-02 with the coding gene of β-ketoacyl-ACP synthase III in Bacillus, and the promoter of the coding gene of β-ketoacyl-ACP synthase III is P43 promoter.
[0016] Compared with the prior art, the present invention has the following advantages:
[0017] The present invention integrates and overexpresses the fabHB gene (the gene encodes β-ketoacyl-ACP synthase III) into the Bacillus licheniformis genome to obtain a Bacillus licheniformis expression system capable of efficiently secreting poly-gamma-glutamate, nattokinase, and alkaline protease, thereby laying a foundation for the efficient secretion of polypeptides and promoting the efficient synthesis of poly-gamma-glutamate, the efficient expression of alkaline protease and nattokinase, and the industrialized production. DETAILED DESCRIPTION
[0018] The technical solutions described in the present invention, unless otherwise specified, are all conventional solutions in the art; the reagents or materials described, unless otherwise specified, are all from commercial channels.
[0019] Embodiment 1:
[0020] Construction of Bacillus licheniformis expressing β-ketoacyl-ACP synthase Ⅲ
[0021] The method for constructing WX-02::P43-fabHB comprises the following steps:
[0022] (1) According to the gene sequence of the fabHB gene in the genomic DNA sequence of Bacillus licheniformis WX-02 (CN110951797A), the upstream primer (P43-fabHB-F2) and the downstream primer (P43-fabHB-R2) of the fabHB gene were designed; and the genomic DNA of Bacillus licheniformis WX-02 was used as a template to perform PCR amplification with the upstream primer and the downstream primer of the fabHB gene to obtain the fabHB gene fragment;
[0023] Wherein, the sequences of primers P43-fabHB-F2 and P43-fabHB-R2 are:
[0024] P43-fabHB-F2: ATGAAAACTTTATCAAAAGCGCGAAP43-fabHB-R2: TCCGTCCTCTCTGCTCTTTCAGGAAGCTGGCGCGCC; the amplified fabHB gene is shown in SEQ ID NO.1, and the encoded protein is shown in SEQ ID NO.2.
[0025] (2) Using the genomic DNA of Bacillus subtilis 168 as a template, PCR amplification was performed to obtain the P43 promoter (the primers used were fabHB-P43-F and fabHB-P43-R); using the genomic DNA of Bacillus licheniformis WX-02 as a template, PCR amplification was performed to obtain the amylase terminator (the primers used were P43-fabHB-F3 and P43-fabHB-R3), and then the promoter, target gene fabHB and terminator were connected together by SOE-PCR (the primers used were fabHB-P43-F and P43-fabHB-R3) to form a complete fabHB expression element;
[0026] The sequences of primers fabHB-P43-F, fabHB-P43-R, P43-fabHB-F3, and P43-fabHB-R3 are as follows: fabHB-P43-F: TGGGGCTGAAAAGCGACGTGATAGGTGGTATGTTTT fabHB-P43-R: TGGGGCTGAAAAGCGACGTGATAGGTGGTATGTTTT
[0027] P43-fabHB-F3:GGCGCGCCAGCTTCCTGAAAGAGCAGAGAGGACGGA
[0028] P43-fabHB-R3:CTCCGACAAGCCCGAAACATCCGTCACAGTCTCAG
[0029] (3) According to the upstream and downstream sequences of the sigE gene in the genomic DNA sequence of Bacillus licheniformis WX-02, upstream homology arm primers (P43-fabHB-F1 and P43-fabHB-R1) and downstream homology arm primers (P43-fabHB-F4 and P43-fabHB-R4) of the sigE gene were designed; and the genomic DNA of Bacillus licheniformis WX-02 was used as a template to perform PCR amplification using the upstream homology arm primer and the downstream homology arm primer of the sigE gene to obtain the upstream homology arm of the sigE gene and the downstream homology arm of the sigE gene;
[0030] The sequences of primers P43-fabHB-F1, P43-fabHB-R1, P43-fabHB-F4, and P43-fabHB-R4 are P43-fabHB-F1: ACGGCCAGTGCCAAGCTTAGGCCTGCATTGGTGAAC
[0031] P43-fabHB-R1:CGTCGCTTTTTCAGCCCCA
[0032] P43-fabHB-F4: CTGAGACTGTGACGGATGGTTTCGGGCTTGTCGGAG
[0033] P43-fabHB-R4:TGACATGATTACGAATTCGAAAACTTAACATTGTGG
[0034] (4) The upstream homologous arm of the sigE gene, the fabHB expression element, and the downstream homologous arm of the sigE gene were connected together by overlapping extension PCR (the primers used were P43-fabHB-F1 and P43-fabHB-R4) to form a target gene fragment, and the order of arrangement of the target gene fragment was: upstream homologous arm of the sigE gene-fabHB expression element-downstream homologous arm of the sigE gene; wherein sigE is a gene that controls the spore formation process of Bacillus;
[0035] (5) double digesting the target gene fragment with SacI and XbaI restriction endonucleases to obtain a digested gene fragment. At the same time, double digesting the plasmid T2(2)-ori with SacI and XbaI restriction endonucleases to obtain a linear plasmid fragment;
[0036] (6) Connecting the cleaved gene fragment and the linearized plasmid fragment using DNA ligase to obtain the integration plasmid T2(2)-P43-fabHB;
[0037] (7) The integration plasmid T2(2)-P43-fabHB was transformed into Bacillus licheniformis WX-02, and kanamycin resistance was used as a selection marker to screen for positive transformants;
[0038] (8) After the positive transformants were transferred and cultured several times at 45°C, colony PCR was performed to obtain a positive single-crossover conjugant strain in which the upstream homologous arm of the sigE gene or the downstream homologous arm of the sigE gene produced a single crossover with the genomic DNA of Bacillus licheniformis WX-02;
[0039] (9) The positive single-crossover conjugant strains that produce single crossover between the upstream homologous arm of the sigE gene and the genomic DNA of Bacillus licheniformis WX-02 or the positive single-crossover conjugant strains that produce single crossover between the downstream homologous arm of the sigE gene and the genomic DNA of Bacillus licheniformis WX-02 are selected and mixed and inoculated in a culture medium without kanamycin at 37°C. After several transfer cultures, the Bacillus licheniformis WX-02::P43-fabHB with the integrated fabHB gene is screened by PCR.
[0040] Other promoter groups: Replace the fabHB gene promoter P43 in WX-02::P43-fabHB;
[0041] Among them, WX-02::PykzA-fabHB is a sequence in which the promoter P43 in the fabHB expression element is replaced with PykzA;
[0042] WX-02::PnadE-fabHB is a gene in which the promoter P43 in the fabHB expression element is replaced by PnadE.
[0043] The construction method of WX-02::PykzA-fabHB comprises the following steps:
[0044] (1) The fabHB gene fragment was amplified according to the WX-02::P43-fabHB method.
[0045] (2) Using the genomic DNA of Bacillus subtilis 168 as a template, PCR amplification was performed to obtain the PykzA promoter (the primers used were fabHB-PykzA-F and fabHB-PykzA-R); using the genomic DNA of Bacillus licheniformis WX-02 as a template, PCR amplification was performed to obtain the amylase terminator, and then the promoter, target gene and terminator were connected together by SOE-PCR (the primers used were fabHB-PnadE-F and P43-fabHB-R3) to form a complete fabHB expression element;
[0046] The primers fabHB-PykzA-F, fabHB-PykzA-R,
[0047] fabHB-PykzA-F:TGGGGCTGAAAAGCGACGGAAATATTGATGTGACAC
[0048] fabHB-PykzA-R: TTTTGATAAAGTTTTCATATTTCCCAACCTCCTTAT.
[0049] The remaining steps were the same as those of WX-02::P43-fabHB, and finally, the licheniformis strain WX-02::PykzA-fabHB integrated with the fabHB gene was prepared.
[0050] The construction method of WX-02::PnadE-fabHB comprises the following steps:
[0051] (1) The fabHB gene fragment was amplified according to the WX-02::P43-fabHB method.
[0052] (2) Using the genomic DNA of Bacillus subtilis 168 as a template, PCR amplification was performed to obtain the PnadE promoter (the primers used were fabHB-PnadE-F and fabHB-PnadE-R); using the genomic DNA of Bacillus licheniformis WX-02 as a template, PCR amplification was performed to obtain the amylase terminator (the primers used were P43-fabHB-F3 and P43-fabHB-R3), and then the promoter, target gene and terminator were connected together by SOE-PCR (the primers used were fabHB-PnadE-F and P43-fabHB-R3) to form a complete fabHB expression element;
[0053] fabHB-PnadE-F: TGGGGCTGAAAAGCGACGCTTTGCGCACCTCAATATTC
[0054] fabHB-PnadE-R: TTTTGATAAAGTTTTCATCCGTCACTCCTCCTTTTG.
[0055] The remaining steps were the same as those of WX-02::P43-fabHB, and finally, the Bacillus licheniformis WX-02::PnadE-fabHB integrated with the fabHB gene was prepared.
[0056] Embodiment 2:
[0057] Application of Bacillus licheniformis WX-02::P43-fabHB in high expression of alkaline protease:
[0058] (1) Construction of alkaline protease expression strain: The expression vector containing the alkaline protease gene aprE expression cassette (ZL202210471439.7) was electroporated into Bacillus licheniformis WX-02 and WX-02::PykzA-fabHB, WX-02::P43-fabHB, and WX-02::PnadE-fabHB, respectively, to obtain Bacillus licheniformis WX / aprE, WX-02::PykzA-fabHB / aprE, WX-02::P43-fabHB / aprE, and WX-02::PnadE-fabHB / aprE with high alkaline protease production.
[0059] (2) The alkaline protease engineered strain constructed above was activated on a tetracycline resistance plate, and then a single colony was picked into a PA bottle containing the corresponding resistance, and cultured at 37°C, 230rpm for 12h. A 2% inoculation amount was inoculated into 50mL seed solution containing the corresponding resistance, and cultured at 37°C, 230rpm for 12h until OD600 reached 4.0-4.5. Finally, a 3% inoculation amount was inoculated into 20mL alkaline protease fermentation medium, and cultured at 37°C, 230rpm for 63h to obtain a fermentation broth. 2mL of the fermentation broth was centrifuged at 12000rpm for 10min, and the supernatant was the crude alkaline protease enzyme solution.
[0060] The seed solution: 10g / L peptone, 5g / L yeast extract powder, 10g / L sodium chloride pH7.2-7.4, 250mL triangular bottle liquid volume is 50mL;
[0061] Fermentation medium: soybean meal 80g / L, peptone 5g / L, sodium caseinate 2g / L, ferric chloride 0.02g / L, dipotassium hydrogen phosphate 2g / L, calcium chloride 4g / L, glucose 20g / L, pH 7.2-7.4, liquid volume is 20mL in a 250mL conical flask.
[0062] Add 100μL of 3% azocasein solution to 1.3mL of glycine-NaOH (pH 10.0) buffer and keep it in a 50℃ water bath for 2min; add 100μL of appropriately diluted enzyme solution and react for 20min; immediately add 500μL of 10% TCA solution to terminate the reaction, shake well, and let stand at room temperature for 20min; centrifuge at 12000×g for 10min to precipitate the unreacted substrate; take 1.6mL of supernatant, add it to 400μL of 2mol·L-1NaOH solution for color development, mix well and measure the absorbance at 440nm. Enzyme activity definition: Under specific conditions, the amount of enzyme required to produce a 0.01 absorbance change within 1min is defined as one enzyme activity unit.
[0063]
[0064] It can be seen that although the fabHB gene was introduced into both strains, the alkaline protease activity of the engineered bacteria using only the P43 promoter was significantly improved compared with the wild-type strain.
[0065] Embodiment 3:
[0066] Application of Bacillus licheniformis WX-02::PnadE-fabHB in high expression of nattokinase:
[0067] (1) Construction of nattokinase expression strain: The expression vector containing the nattokinase gene aprN expression cassette was
[0068] (ZL201410417443.0) were electroporated into Bacillus licheniformis WX-02 and WX-02::PykzA-fabHB, WX-02::P43-fabHB, and WX-02::PnadE-fabHB, respectively, to obtain Bacillus licheniformis WX / aprN, WX-02::PykzA-fabHB / aprN, WX-02::P43-fabHB / aprN, and WX-02::PnadE-fabHB / aprN with high nattokinase production.
[0069] (2) The nattokinase engineering strain constructed above was activated on a tetracycline resistance plate, and then a single colony was picked into a PA bottle containing the corresponding resistance, and cultured at 37°C, 230rpm for 12h. A 2% inoculum was inoculated into 50mL seed solution containing the corresponding resistance, and cultured at 37°C, 230rpm for 12h until OD600 reached 4.0-4.5. Finally, a 3% inoculum was inoculated into 30mL nattokinase fermentation medium, and cultured at 37°C, 230rpm for 48h to obtain a fermentation broth.
[0070] The seed solution: 10g / L peptone, 5g / L yeast extract powder, 10g / L sodium chloride, pH 7.2-7.4, 250mL triangular bottle liquid volume is 50mL
[0071] The fermentation medium comprises: 10 g / L soybean peptone, 10 g / L corn steep liquor centrifuge, 10 g / L bone peptone, 15 g / L yeast extract, 3 g / L dipotassium hydrogen phosphate, 6 g / L ammonium sulfate, 20 g / L glucose, the pH value is adjusted to 7.2, and the liquid volume is 30 mL per 250 mL conical flask.
[0072] 2 mL of fermentation broth was centrifuged at 12000 rpm for 10 min, and the supernatant was the crude enzyme solution of nattokinase. In this application, the crude enzyme solution of nattokinase was used to detect enzyme activity, and the crude enzyme solution was diluted to a suitable multiple with Tris-Hcl (50 mM, pH 7.8) for enzyme activity detection.
[0073] Fibrinogen is converted into fibrin, and fibrin is the substrate for the nattokinase enzyme activity detection reaction. First, take 0.4mL of fibrinogen solution (0.72%) into a test tube, add 1.4mL of Tris-Hcl (50mM, pH7.8), place it in a 37℃ water bath for 3min, add 0.1mL of thrombin (20U / mL), shake it gently and then bathe it in 37℃ water bath for 10min, and wait for fibrinogen to be converted into fibrin. After 10min, the conversion is completed, add 0.1mL of diluted nattokinase crude enzyme solution, shake the test tube gently to mix, set the blank group without adding enzyme solution, react in a 37℃ water bath for 60min, then add 2mL of trichloroacetic acid (200mM) to terminate the reaction, and then add trichloroacetic acid and diluted enzyme solution to the blank group. React at 37℃ for 20min, and centrifuge the reaction solution at 12000rpm for 10min. The absorbance at 275 nm was detected using a quartz cuvette and an ultraviolet spectrophotometer, and the blank group was used for zero calibration to control the absorbance between 0.060 and 0.080.
[0074]
[0075] It can be seen that although the fabHB gene was introduced into both strains, the alkaline protease activity of the engineered bacteria using only the PnadE promoter was significantly improved compared with the wild-type strain.
[0076] Embodiment 4:
[0077] Application of Bacillus licheniformis WX-02::P43-fabHB in high expression of poly-γ-glutamic acid:
[0078] The WX-02 strain itself can produce poly-γ-glutamic acid.
[0079] In this example, the ability of Bacillus licheniformis WX-02::PykzA-fabHB, WX-02::P43-fabHB, and WX-02::PnadE-fabHB to produce poly-γ-glutamate was investigated, and it was found that the ability of the three fabHB engineered bacteria to produce poly-γ-glutamate was significantly improved compared to the control strain WX-02, indicating that the replacement of the promoter has no significant effect on the gene, as long as the gene can be activated for overexpression.
[0080] Further, the applicant took WX-02::P43-fabHB as an example, and investigated the ability of Bacillus licheniformis WX-02::P43-fabHB to produce poly-gamma-glutamic acid for different poly-gamma-glutamic acid fermentation medium formulas (Bacillus licheniformis WX-02 was also inoculated in these 18 culture media as a control). The specific formulas of the 18 groups of culture media are shown in Table 1:
[0081] Table 1
[0082] Glucose (g / L) Sodium glutamate (g / L) Sodium citrate(g / L) Recipe 1 60 20 10 Recipe 2 60 30 10 Recipe 3 60 40 10 Recipe 4 60 30 12.5 Recipe 5 60 30 15 Recipe 6 60 30 17.5 Recipe 7 70 20 10 Recipe 8 70 30 10 Recipe 9 70 40 10 Recipe 10 70 30 12.5 Recipe 11 70 30 15 Recipe 12 70 30 17.5 Recipe 13 80 20 10 Recipe 14 80 30 10 Recipe 15 80 40 10 Recipe 16 80 30 12.5 Recipe 17 80 30 15 Recipe 18 80 30 17.5
[0083] The other components in the 18 culture media were: 10 g / L NaNO3, 8 g / L NH4Cl, 1 g / L K2HPO4·3H2O, 1 g / LMgSO4·7H2O, 1 g / L ZnSO4·7H2O, 0.15 g / L MnSO4·H2O, 1 g / L CaCl2, pH 7.2.
[0084] Among them, the above embodiment is the strain constructed by the present invention; the specific steps of obtaining the seed solution are: first activate Bacillus licheniformis, that is, inoculate 1% by volume from the glycerol tube into 5mL LB culture medium, 180-300r / min, temperature 37°C, culture for 10-14 hours, then inoculate the activated bacterial solution into the seed fermentation medium at a volume percentage of 1% inoculation amount, and then culture at 180-300r / min, 37°C for 10-12 hours to obtain a seed culture bacterial solution;
[0085] The specific steps of fermentation are: 50% of the production fermentation medium is added to a 500mL triangular flask, and then the seed culture bacterial solution is inoculated with an inoculation amount of 3% (volume percentage), a rotation speed of 230r / min, a temperature of 37°C, and fermented for 30 hours to obtain the production fermentation bacterial solution. The specific steps of obtaining the seed solution and fermentation are all prior art.
[0086] The CTAB method (Halmschlag et al, 2009) was used to measure the yield of γ-PGA. The specific steps are as follows: 2.00 g of fermentation broth was added with 4 mL of pH = 1 HCl solution and mixed, and centrifuged at 12000 rpm / min for 5 min; the supernatant was taken to adjust the pH to neutral, and after adding three times the volume of ethanol and shaking, the wet sample was taken to re-dissolve, and the concentration of the test sample was controlled at 0-0.10 g / L. 100 uL of 0.15 M CTAB 2% NaOH solution was added for reaction, and OD400 nm was detected after 3-5 min of reaction. The concentration of γ-PGA was calculated according to the standard curve.
[0087] Table 2
[0088]
[0089] It can be seen from Table 2 that under the same fermentation conditions, the yield of γ-PGA in the fermented bacterial liquid using the Bacillus licheniformis WX-02::P43-fabHB of the present invention is greatly improved (increased by more than 31.02%) compared with the control bacteria, indicating that the technical solution of the present invention has great application value in increasing the yield of γ-PGA in Bacillus licheniformis.
Claims
1. Application of β-ketoacyl-ACP synthase III in Bacillus to promote the secretion efficiency of Bacillus metabolites, wherein the β-ketoacyl-ACP synthase III is shown in SEQ ID NO.
2.
2. The use according to claim 1, wherein the Bacillus is Bacillus licheniformis.
3. The use according to claim 1, wherein the gene encoding β-ketoacyl-ACP synthase III is shown in SEQ ID NO.
1.
4. The use according to claim 2, wherein the Bacillus is Bacillus licheniformis WX-02.
5. The application according to claim 4, wherein the application process comprises: Replace the gene encoding β-ketoacyl-ACP synthase III in Bacillus with that in Bacillus licheniformis WX-02 sigE Gene.
6. The use according to claim 1, wherein the Bacillus metabolite is γ-PGA, a metabolite of Bacillus licheniformis.
7. Application of β-ketoacyl-ACP synthase III in Bacillus to promote the expression of exogenous proteins in Bacillus licheniformis.
8. The use according to claim 7, wherein the exogenous protein is nattokinase or alkaline protease.
9. The use according to claim 8, when the exogenous protein is nattokinase, the use process comprises replacing the gene encoding β-ketoacyl-ACP synthase III in Bacillus with the gene encoding β-ketoacyl-ACP synthase III in Bacillus licheniformis WX-02. sigE Gene, and the promoter of the gene encoding β-ketoacyl-ACP synthase III is the PnadE promoter.
10. The use according to claim 9, when the exogenous protein is alkaline protease, the use process comprises replacing the gene encoding β-ketoacyl-ACP synthase III in Bacillus with the gene encoding β-ketoacyl-ACP synthase III in Bacillus licheniformis WX-02. sigE Gene, and the promoter of the gene encoding β-ketoacyl-ACP synthase III is P43 promoter.
Citation Information
Patent Citations
Bacillus licheniformis engineering bacteria for nattokinase production and method for producing nattokinase by using bacillus licheniformis engineering bacteria
CN104630124A
Ketoacyl acp synthase genes and uses thereof
CN106574255A
Method for improving heterologous protein secretion level of bacillus licheniformis
CN106893736A
Application of Peptostreptococcus asaccharoly glutamate dehydrogenase (GdhA) in increasing yield of Bacillus licheniformis poly-gamma-glutamic acid
CN110951797A
Bacillus licheniformis for enhancing expression of cysP and preparation method and application thereof
CN111304235A
